<DOC>
	<DOCNO>NCT02574962</DOCNO>
	<brief_summary>The purpose pilot study assess safety efficacy Acthar® Gel Chronic Inflammatory Demyelinating Polyneuropathy ( CIDP ) patient .</brief_summary>
	<brief_title>Pilot Study Acthar® Gel Chronic Inflammatory Demyelinating Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Polyradiculoneuropathy , Chronic Inflammatory Demyelinating</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<criteria>CIDP diagnose accord European Federation Neurological Societies/Peripheral Nerve Society ( EFNS/PNS ) criterion 2010 Age &gt; 18 year Able give write informed consent Patient 's sign symptom well explain another disease process Patients prednisone long dose change 4 week baseline Patients follow drug long change 60 day baseline visit include azathioprine , cyclosporine , cyclophosphamide , mycophenolate mofetil , intravenous immunoglobulin ( IVIg ) immunosuppressive drug INCAT score great equal 2 Presence cause polyneuropathy multifocal motor neuropathy , opinion investigator major contributor numbness weakness . Other neurologic orthopedic condition cause weakness Treatment plasma exchange ( PLEX ) within last 30 day baseline Participation another trial within last 30 day baseline two ½ life drug study . Latent tuberculosis active infection Contraindication per Acthar® Gel prescribe information scleroderma , osteoporosis , systemic fungal infection , ocular herpes simplex , recent surgery , history presence peptic ulcer , congestive heart failure , uncontrolled hypertension , primary adrenocortical insufficiency , adrenal cortical hyperfunction . History prior sensitivity Acthar® Gel porcine product Previous present Infection hepatitis C hepatitis B Pregnancy nursing mother . Female subject childbearing potential either use , willing use , medically reliable method contraception entire duration study , sexually abstinent entire duration study , surgically sterile .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>